MDF staff recently attended the 2017 annual meeting of the American Academy of Neurology, in Boston, MA. Here are highlights from that meeting.
There have been new discoveries in the way that congenital myotonic dystrophy (CDM) is inherited.
MDF is also happy to help you understand whether something is in a legitimate clinical trial, an approved therapy…or not.
Important review articles on disease mechanisms of and therapy development for DM have recently been published.
The UK DM Patient Registry reports on disease burden for 556 patients with a confirmed diagnosis of DM1.